Mehiläinen buys Romania and Serbian leading health service companies

After the acquisition, Mehiläinen estimates that he is the fourth largest employer company in Finland in terms of staff.

The abstract is made by artificial intelligence and checked by man.

Health service giant Mehiläinen acquires Romania and Serbia’s leading health service companies Regina Maria and Medigroup.

Mehiläinen says he raised EUR 2.6 billion in funds in his recent financial round.

With the acquisitions, Mehiläinen becomes Finland’s fourth largest employer company with about 54,000 employees, says the company.

Health service giant Mehiläinen has signed agreements on purchases from Romania and Serbia’s leading health service companies, Regina Maria and Medigroup, says Mehiläinen.

The implementation of acquisitions and ownership arrangements requires authority approval.

Acquisition As part of the US venture capitalist Hellman & Friedman, it will make a significant investment in Mehiläinen.

Mehiläinen says he raised EUR 2.6 billion in funds in his recent financial round.

It estimates in its announcement the realized venture capital investment is “one of the largest in history, if not the largest single international venture capitalization round of a Finnish company”.

Part of the large amount is due to the transfer of Mehiläinen’s ownership from its old majority owner CVC funds to other CVC funds.

Regina Maria is a leading health service company in Romania, offering a wide range of 11,000 professionals in about 300 professionals for more than two million clients every year, Mehiläinen says in the release.

Regina Maria’s sister company Medigroup, on the other hand, is Serbia’s leading player in the private health service market with about 100 units and over 2,500 staff. The total turnover of the companies was approximately EUR 550 million in 2024.

The salesman in the acquisition is the venture capitalist Mideuropa.

Bee is a majority owned by CVC Capital Partners in Luxembourg. It owned 57 percent of Mehiläinen.

After the entry of Hellman & Friedman, these two venture capitalists own a majority of Mehiläinen.

Other significant direct owners include the company’s leadership and key personnel and Finnish institutions Varma, the State Pension Fund and Ilmarinen.

According to the company’s estimation, the share of personnel is in the order of well over ten percent.

Bee managing director Janne-Olli to Järvenpää Expanding to two new European countries is another one of the rapid growth of the rapid growth.

Before this shop, Mehiläinen was already buying an Inmedica Health Service company in Lithuania.

Järvenpää has been CEO of Mehiläinen ever since Mehiläinen acquired Mediverko in 2015, where he was CEO and one of the four founding shareholders.

Last In Mehiläinen’s net sales, EUR 2.1 billion.

According to Järvenpää, about half of the turnover comes from Mediverkko’s initiation of public services in the social and health services sector.

When Mediverkko merged in 2015 with Mehiläinen, he had a thousand full -time employees and a turnover of EUR 100 million, ie Mediverkko’s net sales have been approximately tenfold in ten years.

As a result of the acquisitions, more than 8,000 full-time employees will be transferred to the Mehiläinen Group.

According to the company, the number of people working in the Group will increase to about 54,000, corresponding to about 26,000 full -time employees.

“Mehiläinen’s number of staff has increased tenfold in 10 years. In 2014, Mehiläinen had 2,540 full -time employees,” says Järvenpää.

“With this global number of staff, Mehiläinen will become Finland’s fourth largest employer company after Nokia, Kone and Nordea. Mehiläinen is already the largest private employer in Finland,” says Mehiläinen.

Lake says Mehiläinen’s leadership has made a thorough due diligence– That is, a diligence examination of the purchasing items for about a year and a half.

“Of course, management has to do a lot of work,” Järvenpää says.

“The close phase lasted from the beginning of September to the present day.”

Contractors Do not disclose the ENTERPRISE VALUE (ENTERprise Value) estimated in the financing round.

According to enlightened estimates, Mehiläinen’s debt -free corporate value is around EUR 6 billion.

Järvenpää says he owns “a few percent of Mehiläinen.”

 

 

TT slice shooting device at the Docrates Mehiläinen Cancer Hospital in Helsinki on March 26, 2025. Docrates is one of Mehiläinen’s many acquisitions.

By Editor

Leave a Reply